ILMN
ILLUMINA, INC.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$239.62
−2.27%Next report
Analyst consensus
- Next report date
- Oct 29, 2026
- EPS estimate
- $1.36
- Revenue estimate
- $1.2B
Latest reported
- Last report date
- Jul 30, 2026
- EPS actual
- $1.31
- EPS estimate
- $1.23
- Revenue actual
- $1.2B
- Revenue estimate
- $1.1B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 10
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +9.4%
- Revenue beats (12Q)
- 9
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $210
- PT range
- $113 – $260
- Analysts
- 14
10 Buy2 Hold2 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 30, 2026 | $1.23 | $1.31 | Beat 6.50% | $1.2B |
| Apr 30, 2026 | $1.05 | $1.15 | Beat 9.52% | $1.1B |
| Feb 5, 2026 | $1.26 | $1.35 | Beat 7.14% | $1.2B |
| Oct 30, 2025 | $1.17 | $1.34 | Beat 14.53% | $1.1B |
| Jul 31, 2025 | $1.02 | $1.19 | Beat 16.67% | $1.1B |
| May 8, 2025 | $0.94 | $0.97 | Beat 3.19% | $1.0B |
| Feb 6, 2025 | $0.92 | $0.86 | Miss -6.52% | $1.1B |
| May 2, 2024 | $0.04 | $0.09 | Beat 106.42% | $1.1B |
| Feb 8, 2024 | $0.02 | $0.14 | Beat 686.08% | $1.1B |
| Nov 9, 2023 | $0.13 | $0.33 | Beat 153.85% | $1.1B |
| Feb 7, 2023 | $0.19 | $0.14 | Miss -26.32% | $1.1B |
| Nov 3, 2022 | $0.29 | $0.34 | Beat 17.24% | $1.1B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 29, 2026